For: | Liu XY, Guo CH, Xi ZY, Xu XQ, Zhao QY, Li LS, Wang Y. Histone methylation in pancreatic cancer and its clinical implications. World J Gastroenterol 2021; 27(36): 6004-6024 [PMID: 34629816 DOI: 10.3748/wjg.v27.i36.6004] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v27/i36/6004.htm |
Number | Citing Articles |
1 |
Krzysztof Szymoński, Katarzyna Skirlińska-Nosek, Ewelina Lipiec, Kamila Sofińska, Michał Czaja, Natalia Wilkosz, Matylda Krupa, Filip Wanat, Magdalena Ulatowska-Białas, Dariusz Adamek. Combined analytical approach empowers precise spectroscopic interpretation of subcellular components of pancreatic cancer cells. Analytical and Bioanalytical Chemistry 2023; 415(29-30): 7281 doi: 10.1007/s00216-023-04997-w
|
2 |
Ebru Erzurumluoğlu Gökalp, Sevgi Işık, Sevilhan Artan. Cancer Epigenetics. Epigenetics and Human Health 2023; 11: 77 doi: 10.1007/978-3-031-42365-9_3
|
3 |
Gengjun Zhu, Lifang Jin, Wanchun Sun, Shuang Wang, Ning Liu. Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(4): 188735 doi: 10.1016/j.bbcan.2022.188735
|
4 |
Yuhao Zhao, Mao Yang, Shijia Wang, Sk Jahir Abbas, Junzhe Zhang, Yongsheng Li, Rong Shao, Yingbin Liu. An Overview of Epigenetic Methylation in Pancreatic Cancer Progression. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.854773
|
5 |
Marzieh Jamali, Erfaneh Barar, Jiaqi Shi. Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex. International Journal of Molecular Sciences 2024; 25(10): 5069 doi: 10.3390/ijms25105069
|
6 |
Lei Jin, Daohai Qian, Xiaolei Tang, Yong Huang, Junwei Zou, Zhaoying Wu. SMYD2 Imparts Gemcitabine Resistance to Pancreatic Adenocarcinoma Cells by Upregulating EVI2A. Molecular Biotechnology 2024; 66(10): 2920 doi: 10.1007/s12033-023-00908-7
|
7 |
L. Tharrun Daniel Paul, Ganesh Munuswamy-Ramanujam, Rajappan Chandra Satish Kumar, Vasukidevi Ramachandran, Dhanavathy Gnanasampanthapandian, Kanagaraj Palaniyandi. Biomarkers in Cancer Detection and Monitoring of Therapeutics. 2024; : 121 doi: 10.1016/B978-0-323-95114-2.00025-X
|
8 |
Eunji Hong, Wojciech Barczak, Sujin Park, Jin Sun Heo, Akira Ooshima, Shonagh Munro, Chang Pyo Hong, Jinah Park, Haein An, Joon Oh Park, Seok Hee Park, Nick B. La Thangue, Seong-Jin Kim. Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors. Cell Death & Disease 2023; 14(2) doi: 10.1038/s41419-023-05630-5
|
9 |
Renzo Vera, María Julia Lamberti, Alina L. Gonzalez, Martín E. Fernandez-Zapico. Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer. Pancreatology 2024; 24(6): 878 doi: 10.1016/j.pan.2024.07.005
|
10 |
Lei Zhu, Dong Tu, Ruixue Li, Lin Li, Wenjie Zhang, Wenxiang Jin, Tiehan Li, Hong Zhu. The diagnostic significance of the ZNF gene family in pancreatic cancer: a bioinformatics and experimental study. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1089023
|
11 |
Suvasmita Rath, Diptesh Chakraborty, Jyotsnarani Pradhan, Mohammad Imran Khan, Jagneshwar Dandapat. Epigenomic interplay in tumor heterogeneity: Potential of epidrugs as adjunct therapy. Cytokine 2022; 157: 155967 doi: 10.1016/j.cyto.2022.155967
|
12 |
Kayla C. LaRue-Nolan, Glancis Luzeena Raja Arul, Ashley N. Sigafoos, Jiaqi Shi, Martin E. Fernandez-Zapico. Insights into the mechanisms driven by H3K4 KMTs in pancreatic cancer. Biochemical Journal 2024; 481(15): 983 doi: 10.1042/BCJ20230374
|
13 |
Lei Yang, Qiqiong Zhang, Qiuye Yang. KDM3A promotes oral squamous cell carcinoma cell proliferation and invasion via H3K9me2 demethylation-activated DCLK1. Genes & Genomics 2022; 44(11): 1333 doi: 10.1007/s13258-022-01287-0
|
14 |
Yunxia Wang, Xiaolin Liu, Luyao Gong, Weihong Ding, Wenjing Hao, Yeheng Peng, Jun Zhang, Weimin Cai, Yuan Gao. Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics. British Journal of Pharmacology 2023; 180(23): 2937 doi: 10.1111/bph.16252
|
15 |
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, Sofía Madeline Osorio-Pérez, Hania Ruth Zlotnik-Chávez, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. Translational Oncology 2023; 27: 101579 doi: 10.1016/j.tranon.2022.101579
|